ESOPHAGEAL SQUAMOUS CELL CANCER
Clinical trials for ESOPHAGEAL SQUAMOUS CELL CANCER explained in plain language.
Never miss a new study
Get alerted when new ESOPHAGEAL SQUAMOUS CELL CANCER trials appear
Sign up with your email to follow new studies for ESOPHAGEAL SQUAMOUS CELL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail shows promise for tough cancers
Disease control OngoingThis study tests a new combination of drugs (futibatinib plus standard immunotherapy) in adults with advanced esophageal or pancreatic cancer that cannot be removed by surgery. The goal is to see if the combination shrinks tumors and is safe. About 53 people will take part, and t…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CANCER
Phase: PHASE2 • Sponsor: Taiho Oncology, Inc. • Aim: Disease control
Last updated May 16, 2026 23:38 UTC
-
New drug combo targets tough cancers in early trial
Disease control ENROLLING_BY_INVITATIONThis early-phase study tests an experimental drug called RNDO-564, alone or with pembrolizumab, in adults with advanced solid tumors (like bladder, lung, or breast cancer) that have stopped responding to standard treatments. The main goals are to check safety, find the best dose,…
Matched conditions: ESOPHAGEAL SQUAMOUS CELL CANCER
Phase: PHASE1 • Sponsor: Rondo Therapeutics • Aim: Disease control
Last updated May 06, 2026 16:01 UTC